The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
DPEP1 Inhibits Tumor Cell Invasiveness, Enhances Chemosensitivity and Predicts Clinical Outcome in Pancreatic Ductal Adenocarcinoma
Open accessAbstract
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers worldwide. To identify biologically relevant genes with prognostic and therapeutic significance in PDAC, we first performed the microarray gene-expression profiling in 45 matching pairs of tumor and adjacent non-tumor tissues from resected PDAC cases. We identified 36 genes that were associated with patient outcome and also differentially expressed in tumors as compared with adjacent non-tumor tissues in microarray analysis. Further evaluation in an independent validation cohort (N = 27) confirmed that DPEP1 (dipeptidase 1) expression was decreased (T:N ratio ∼0.1, P<0.01) in tumors as compared with non-tumor tissues. DPEP1 gene expression was negatively correlated with histological grade (Spearman correlation coefficient = -0.35, P = 0.004). Lower expression of DPEP1 in tumors was associated with poor survival (Kaplan Meier log rank) in both test cohort (P = 0.035) and validation cohort (P = 0.016). DPEP1 expression was independently associated with cancer-specific mortality when adjusted for tumor stage and resection margin status in both univariate (hazard ratio = 0.43, 95%CI = 0.24-0.76, P = 0.004) and multivariate analyses (hazard ratio = 0.51, 95%CI = 0.27-0.94, P = 0.032). We further demonstrated that overexpression of DPEP1 suppressed tumor cells invasiveness and increased sensitivity to chemotherapeutic agent Gemcitabine. Our data also showed that growth factor EGF treatment decreased DPEP1 expression and MEK1/2 inhibitor AZD6244 increased DPEP1 expression in vitro, indicating a potential mechanism for DPEP1 gene regulation. Therefore, we provide evidence that DPEP1 plays a role in pancreatic cancer aggressiveness and predicts outcome in patients with resected PDAC. In view of these findings, we propose that DPEP1 may be a candidate target in PDAC for designing improved treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Conroy, T., Desseigne, F., Ychou, M., Bouché, O., Guimbaud, R., Bécouarn, Y., Adenis, A., Raoul, J.-L., Gourgou-Bourgade, S., de la Fouchardière, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011923 · Cited by 7,810
The landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
Oettle, H., Post, S., Neuhaus, P., Gellert, K., Langrehr, J., Ridwelski, K., Schramm, H., Fahlke, J., Zuelke, C., Burkart, C., et al. (2007) · JAMA · doi:10.1001/jama.297.3.267 · Cited by 2,419
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Collisson, E. A., Sadanandam, A., Olson, P., Gibb, W. J., Truitt, M., Gu, S., Cooc, J., Weinkle, J., Kim, G. E., Jakkula, L., et al. (2011) · Nature Medicine · doi:10.1038/nm.2344 · Cited by 1,967
Pathology and Genetics of Tumours of the Digestive System
(2001) · Histopathology · doi:10.1046/j.1365-2559.2001.01219.x · Cited by 1,314
The role of oxidative stress in chemical carcinogenesis.
Klaunig, J. E., Xu, Y., Isenberg, J. S., Bachowski, S., Kolaja, K. L., Jiang, J., Stevenson, D. E., & Walborg, E. F. (1998) · Environmental Health Perspectives · doi:10.1289/ehp.98106s1289 · Cited by 511
Molecular prognostic markers in pancreatic cancer: A systematic review
Garcea, G., Neal, C. P., Pattenden, C. J., Steward, W. P., & Berry, D. P. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.044 · Cited by 259
A Six-Gene Signature Predicts Survival of Patients with Localized Pancreatic Ductal Adenocarcinoma
Stratford, J. K., Bentrem, D. J., Anderson, J. M., Fan, C., Volmar, K. A., Marron, J. S., Routh, E. D., Caskey, L. S., Samuel, J. C., Der, C. J., et al. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000307 · Cited by 244
Meta-analysis of microarray data on pancreatic cancer defines a set of commonly dysregulated genes
Grützmann, R., Boriss, H., Ammerpohl, O., Lüttges, J., Kalthoff, H., Schackert, H. K., Klöppel, G., Saeger, H. D., & Pilarsky, C. (2005) · Oncogene · doi:10.1038/sj.onc.1208696 · Cited by 201
Gemcitabine Resistance in Pancreatic Cancer: Picking the Key Players
Kim, M. P., & Gallick, G. E. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2247 · Cited by 177
Giehl, K., Skripczynski, B., Mansard, A., Menke, A., & Gierschik, P. (2000) · Oncogene · doi:10.1038/sj.onc.1203612 · Cited by 131
Frequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinoma
Fukushige, S., Waldman, F. M., Kimura, M., Abe, T., Furukawa, T., Sunamura, M., Kobari, M., & Horii, A. (1997) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199707)19:3<161::aid-gcc5>3.0.co;2-w · Cited by 127
Validation of TPX2 as a Potential Therapeutic Target in Pancreatic Cancer Cells
Warner, S. L., Stephens, B. J., Nwokenkwo, S., Hostetter, G. H., Sugeng, A., Hidalgo, M. M., Trent, J. M., Han, H., & Hoff, D. D. V. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0077 · Cited by 114
Identifying Molecular Markers for the Early Detection of Pancreatic Neoplasia
Goggins, M. (2007) · Seminars in Oncology · doi:10.1053/j.seminoncol.2007.05.003 · Cited by 109
DPEP1, expressed in the early stages of colon carcinogenesis, affects cancer cell invasiveness
Toiyama, Y., Inoue, Y., Yasuda, H., Saigusa, S., Yokoe, T., Okugawa, Y., Tanaka, K., Miki, C., & Kusunoki, M. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0318-1 · Cited by 44
Gene expression profiles associated with advanced pancreatic cancer.
Campagna, D., Cope, L., Lakkur, S., Henderson, C. M., Laheru, D. A., & Iacobuzio–Donahue, C. A. (2008) · PubMed · Cited by 40
Dipeptidase 1: a candidate tumor-specific molecular marker in colorectal carcinoma
McIver, C. M., Lloyd, J. M., Hewett, P. J., & Hardingham, J. E. (2004) · Cancer Letters · doi:10.1016/j.canlet.2003.11.033 · Cited by 39
Gene-expression profiling in pancreatic cancer
Lopez-Casas, P. P., & López-Fernández, L. A. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.43 · Cited by 32
Austruy, E., Cohen‐Salmon, M., Antignac, C., Béroud, C., Henry, I., Nguyen, V. C., Brugières, L., Junien, C., & Jeanpierre, C. (1993) · PubMed · Cited by 28
Gene Expression Profiling in Lymph Node-Positive and Lymph Node-Negative Pancreatic Cancer
Kim, H. N., Choi, D. W., Lee, K. T., Lee, J. K., Heo, J. S., Choi, S., Paik, S. W., Rhee, P., & Lowe, A. W. (2007) · Pancreas · doi:10.1097/mpa.0b013e3180317b01 · Cited by 28
Okamoto, T., Matsumura, N., Mandai, M., Oura, T., Yamanishi, Y., Horiuchi, A., Hamanishi, J., Baba, T., Koshiyama, M., Shiozawa, T., et al. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.204 · Cited by 18
Emerging drugs in the treatment of pancreatic cancer
Mahalingam, D., Kelly, K. R., Swords, R. T., Carew, J. S., Nawrocki, S. T., & Giles, F. J. (2009) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210902972502 · Cited by 16
Prognostic Signature for Pancreatic Cancer: Are We Close?
Yeh, J. J. (2009) · Future Oncology · doi:10.2217/fon.09.12 · Cited by 14
Microarray Technologies for Gene Transcript Analysis in Pancreatic Cancer
Kolbert, C. P., Chari, S. T., & Sreekumar, R. (2008) · Technology in Cancer Research & Treatment · doi:10.1177/153303460800700107 · Cited by 7
Cited by
Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling
Weissmueller, S., Manchado, E., Saborowski, M., Morris, J. P., Wagenblast, E., Davis, C. A., Moon, S.-H., Pfister, N. T., Tschaharganeh, D. F., Kitzing, T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.01.066 · Cited by 466
Zhang, G., He, P., Tan, H., Budhu, A., Gaedcke, J., Ghadimi, B. M., Ried, T., Yfantis, H. G., Lee, D. H., Maitra, A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0209 · Cited by 350
Self-citationSIRT6 Suppresses Pancreatic Cancer through Control of Lin28b
Kugel, S., Sebastián, C., Fitamant, J., Ross, K. N., Saha, S. K., Jain, E., Gladden, A., Arora, K. S., Kato, Y., Rivera, M. N., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.033 · Cited by 294
A 25-gene classifier predicts overall survival in resectable pancreatic cancer
Birnbaum, D. J., Finetti, P., Lopresti, A., Gilabert, M., Poizat, F., Raoul, J.-L., Delpero, J.-R., Moutardier, V., Birnbaum, D., Mamessier, E., et al. (2017) · BMC Medicine · doi:10.1186/s12916-017-0936-z · Cited by 51
Almeida, P. P., Cardoso, C. P., & de Freitas, L. M. (2020) · BMC Cancer · doi:10.1186/s12885-020-6533-0 · Cited by 48
Metadata
- Authors
- Zhang, G., Schetter, A., He, P., Funamizu, N., Gaedcke, J., Ghadimi, B. M., Ried, T., Hassan, R., Yfantis, H. G., Lee, D. H., Lacy, C., Maitra, A., Hanna, N., Alexander, H. R., & Hussain, S. P.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-02-20
- Volume
- 7
- Issue
- 2
- Pages
- e31507
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1993782263
- Cited by
- 259
- References
- 25
- FWCI
- 4.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.